Menactra Vaccine
0.5ml Solution For Injection in VialMRP ₹5950.00
₹4879.00
18% OFF
Made by
DR REDDY'S LABORATORIES LTD
Dosage
SOLUTION FOR INJECTION
Expiry
Product Summary
| Uses | Vaccine for meningococcal disease |
| Therapy | Vaccine |
| Side effects | Pain at the injection site, headaches, fatigue, and injection site reactions. |
| Salt Content | Diphtheria Toxoid(48.0 Mcg)+Meningococcal A, C, W And Y Conjugate Vaccine(16.0 Mcg) |
Assurance
available
Regulated
Medical Description
Menactra vaccine is indicated for active immunisation against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals aged 9 months to 55 years. It does not prevent disease caused by N. meningitidis serogroup B. Menactra Vaccine is administered via intramuscular injection.
Invasive meningococcal disease is uncommon but can progress rapidly.. The bacterium lives harmlessly in the nose and throat of some healthy people, but when it invades, it can cause meningitis, inflammation of the lining of the brain and spinal cord, or septicaemia, infection of the bloodstream. Both can become life-threatening within hours and can leave lasting effects such as hearing loss or limb amputation, which is why prevention.
Menactra is a conjugate vaccine.
Common side effects include reactions at the injection site, such as pain, swelling, or redness; irritability; loss of appetite; sleepiness; headache; nausea; vomiting; and diarrhoea. If these side effects do not improve over time or worsen, inform your doctor.
Menactra is administered as a single dose by intramuscular injection, preferably in the anterolateral thigh or deltoid region depending on the recipient's age and muscle mass It must never be self-injected and must never be given into a vein. Younger children may need more than one dose; older children and adults usually receive a single dose, and a booster may be offered to people who remain at risk. Your doctor will set the schedule.
Inform your doctor about any other illnesses you may have had before receiving the vaccine. Disclose all medications you are currently taking. Pregnant and breastfeeding mothers should consult their doctor for advice before getting the vaccine.
Tell the doctor or nurse beforehand if you have a fever on the day, a bleeding or clotting problem, a weakened immune system, a history of Guillain-Barré syndrome, or if you have fainted after an injection before. Stay where you were vaccinated for a short observation period, and keep the vaccination record you are given.
Uses
- For active immunisation to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.
- For use in individuals 9 months through 55 years of age.
Contraindications
- If you have had a severe allergic reaction, such as anaphylaxis, after a previous dose of this or any meningococcal or diphtheria toxoid-containing vaccine.
- If your child is allergic (hypersensitive) to any of the vaccine's ingredients.
Side effects
- Pain, tenderness, redness, swelling or hardening at the injection site
- Headache
- Tiredness and generalised weakness
- Muscle pain and joint pain
- Mild fever or chills
- In infants and young children, irritability, drowsiness, reduced appetite, diarrhoea and vomiting
- Dizziness
- Rash or itching
- Swollen glands in the neck, armpit or groin
- Fainting or feeling faint around the time of the injection, usually related to the injection procedure rather than the vaccine itself
- Severe allergic reaction, with swelling of the face, lips, tongue or throat, difficulty breathing or swallowing, a widespread rash, a sudden drop in blood pressure or collapse
- New or progressive weakness, numbness or tingling that requires urgent assessment, including for possible Guillain-Barré syndrome
- A fit or seizure
- A fever that is high or that is not settling
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have kidney disease or have had a kidney transplant.
- You have liver disease or a history of significant liver problems.
- You have ever been diagnosed with Guillain-Barré Syndrome (GBS), as this condition may recur after vaccination.
- You have a bleeding disorder or a low platelet count (thrombocytopenia), as the vaccine is administered intramuscularly and may pose a risk of bleeding.
- You are taking immunosuppressive medication or have a weakened immune system due to illness or treatment; the vaccine may not be as effective for you.
- You or your child has a high fever or a moderate to severe illness on the day. Vaccination is usually postponed until recovery. A mild cold without fever is not a reason to delay.
- If you have no spleen, a poorly functioning spleen, or a condition affecting the complement system, your risk of meningococcal disease is much higher, and your doctor may recommend additional protection.
Liver
Kidney
Children
Heart
Geriatrics
Allergy
Directions for Use
- A doctor or nurse gives Menactra injection. Do not self-inject this vaccine.
- It is given as a muscle injection preferably in the anterolateral thigh or deltoid region depending on the recipient's age and muscle mass It must never be given into a vein.
- Younger children may need more than one dose for full protection. Older children and adults are usually given a single dose. A booster may be offered to people who remain at continuing risk of meningococcal disease. Your doctor will set the schedule and the intervals.
- Tell the doctor or nurse before the injection about any allergy, any fever on the day, any bleeding problem, and any medicine that affects your immune system.
- Stay where you were vaccinated for a short observation period afterwards so staff can treat any immediate reaction.
- Follow the vaccination schedule your doctor advises and keep the vaccination record you receive.
Storage and disposal
- Store it in a refrigerator at 2-8 degrees C. Keep this out of children's sight.
- Do not freeze. Discard the vaccine if it has been frozen, even if it has thawed and looks normal.
- Store it in the original carton to protect it from light.
- Do not use the vaccine after its expiry date, if the packaging is damaged, or if the contents look unusual.
- Do not dispose of it in household waste or down a drain. The clinic or pharmacy disposes of vaccines and used syringes.
Quick Tips
- Menactra vaccine is recommended for individuals between 9 months and 55 years of age.
- The Menactra vaccine protects against meningococcal disease caused by serogroups A, C, Y, and W-135, but not serogroup B.
- Menactra vaccine is given by intramuscular injection, preferably in the anterolateral thigh or deltoid region, depending on the recipient's age and muscle mass
- Common side effects include pain, redness, or swelling at the injection site, along with irritability, tiredness, headache, nausea, or diarrhea.
- Serious allergic reactions are rare, but you should seek immediate medical attention if you experience symptoms like swelling, hives, or difficulty breathing.
- Protection takes time to build after vaccination, so plan ahead for travel or other situations that raise your risk, rather than waiting until the last moment.
- Meningococcal disease moves quickly. Seek medical help urgently for a severe headache with a stiff neck, dislike of bright light, drowsiness or confusion, or a rash that does not fade when pressed - even if you have been vaccinated.
- Vaccination does not replace other precautions. It covers four groups of the bacterium, not every cause of meningitis.
- Move the vaccinated arm normally and apply a cool compress if the site is sore. Ask your doctor before taking a painkiller, and do not take one beforehand just to prevent side effects.
- Keep your vaccination record and bring it to your next appointment, particularly if a booster may be due.
Dosage
Overdose
Missed a Dose
How does this medicine work?
Interactions
Interactions with other medicines
- Tell your doctor about all medicines, supplements, and herbal products you are taking, and about any vaccine you have had recently or are due to receive.
- Other vaccines: Menactra can generally be given at the same visit as other vaccines, but inject each at a separate site, preferably in a different limb.
- Blood-thinning medicines and low platelet counts: these can increase bleeding or bruising at the injection site. Tell the doctor or nurse before vaccination.
- Medicines that suppress the immune system may reduce the vaccine's effectiveness. Your doctor will assess whether an underlying illness warrants delaying it.
Interactions with food items
Frequently Asked Questions (FAQs)
References:
- Package Insert - Menactra: meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine. Silver Spring (MD): US Food and Drug Administration. [cited 2026 Oct 12]
- Sanofi. Menactra, meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine: product information, solution for injection. [cited 2026 Oct 12]
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO - Menactra, meningococcal (groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine, Sanofi Healthcare India Private Limited, brand record dated 25 October 2021. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare. [cited 2026 Oct 12]
- World Health Organization. Meningococcal vaccines: WHO position paper - November 2011. Weekly Epidemiological Record. Geneva: World Health Organization. [cited 2026 Oct 12]
- World Health Organization. WHO position papers on meningococcal vaccines. Geneva: World Health Organization. [cited 2026 Oct 12]
- World Health Organization. Meningitis: fact sheet. Geneva: World Health Organization. [cited 2026 Oct 12]
- World Health Organization. Immunization, Vaccines and Biologicals: meningitis. Geneva: World Health Organization. [cited 2026 Oct 12]
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:MENACTRA
Manufacturer Name:DR REDDY'S LABORATORIES LTD
Address:Sanofi Pasteur Inc, Address: Discovery Drive, Swiftwater PA 18370-0187 USA
Country of Origin:Usa
Vendor Details
Fulfillment Information: Menactra Vial Of 0.5 Ml Solution For Injection will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.






















